ArQule Message Board - Msg: 3005646

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SteveG who wrote (123)	12/19/1997 7:58:00 AM
From: JZGalt	Read Replies (2) of 399

> This is H&Q's Rachel Leheny's #1 pick. A price target of mid to > upper 20's going into conference has been suggested. Steve, I'm not sure it is her current #1 this year. She wrote on 9/23/97 where she upped ABSC to a Strong Buy when they inked the deal with WLA. Yesterday's deal with MRK should have solidified her position. The original report issued 7/14/97 indicated a price target of $20 a share 12 months out. Not sure if the target changed since then as I don't have access to H&Q reports. My guess is that ABSC will react favorably in January. I'm not down on ARQL, but I own more of ABSC. ---- Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next